Articles dans des revues avec comité de lecture (203)
  1. 13. Bethe, U., Pana, Z. D., Drosten, C., Goossens, H., König, F., Marchant, A., Molenberghs, G., Posch, M., Van Damme, P., & Cornely, O. (2024). Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper. Infection. doi:10.1007/s15010-024-02347-1
  2. 14. Sharma, S., Thiriard, A., Olislagers, V., Lechien, J. R., Jurion, M.-H., Delforge, M.-L., Marchant, A., & Saussez, S. (2024). Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction. Journal of medical virology, 96(1), e29398. doi:10.1002/jmv.29398
  3. 15. Steenackers, K., Hanning, N., Bruckers, L., Desombere, I., Marchant, A., Ariën, K., Georges, D., Soentjens, P., D'Onofrio, V., Hites, M., Berens-Riha, N., De Coster, I., & Damme, P. V. (2024). Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial. Vaccine. doi:10.1016/j.vaccine.2024.07.018
  4. 16. Etienne, I., Kemlin, D., Gemander, N., Olislagers, V., Waegemans, A., Dhondt, E., Heyndrickx, L., Depickère, S., Charles, A., Goossens, M. M., Vandermosten, L., Desombere, I., Ariën, K., Pannus, P., Knoop, C., & Marchant, A. (2024). Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients. The Journal of heart and lung transplantation. doi:10.1016/j.healun.2024.08.002
  5. 17. De Weerdt, L., Thiriard, A., Leuridan, E., Marchant, A., & Maertens, K. (2024). Immunogenicity at delivery after Tdap vaccination in successive pregnancies. Frontiers in immunology, 15, 1360201. doi:10.3389/fimmu.2024.1360201
  6. 18. Marchant, A., Van Damme, P., Plotkin, S., Neels, P., Cassetti, M. C., Cramer, J., Gruber, M. F., Goldblatt, D., King, D., Hartig-Merkel, W., & Vandeputte, J. (2023). Enabling the evaluation of COVID-19 vaccines with correlates of protection. Biologicals, 85, 101723. doi:10.1016/j.biologicals.2023.101723
  7. 19. Hederman, A. P., Natarajan, H., Heyndrickx, L., Ariën, K. K., Wiener, J. A., Wright, P. F., Bloch, E. M., Tobian, A. A. R., Redd, A. D., Blankson, J. N., Rottenstreich, A., Zarbiv, G., Wolf, D., Goetghebuer, T., Marchant, A., & Ackerman, M. M. (2023). SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations. Nature communications, 14(1), 5171. doi:10.1038/s41467-023-40960-0
  8. 20. Giles, M. M., Way, S. S., Marchant, A., Aghaepour, N., James, T., Schaltz-Buchholzer, F., Zazara, D., Arck, P., & Kollmann, T. (2023). Maternal Vaccination to Prevent Adverse Pregnancy Outcomes: An Underutilized Molecular Immunological Intervention? Journal of Molecular Biology, 435(13), 168097. doi:10.1016/j.jmb.2023.168097
  9. 21. Taton, M., Willems, F., Widomski, C., Martin, C., Jiang, Y., Renard, K., Cogan, A., Necsoi, C. V., Ackerman, M. M., Marchant, A., & Dauby, N. (2023). Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization. Vaccine. doi:10.1016/j.vaccine.2023.05.035
  10. 22. Pannus, P., Depickère, S., Kemlin, D., Georges, D., Houben, S., Olislagers, V., Waegemans, A., De Craeye, S., Francotte, A., Chaumont, F., Van Oostveldt, C., Heyndrickx, L., Michiels, J., Willems, E., Dhondt, E., Krauchuk, M., Schmickler, M.-N., Verbrugghe, M., Van Loon, N., Dierick, K., Matagne, A., Desombere, I., Ariën, K. K., Marchant, A., & Goossens, M. M. (2023). Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults. Vaccine, 41(17), 2829-2836. doi:10.1016/j.vaccine.2023.03.047
  11. 23. Erdem, R., De Coster, I., Withanage, K., Mercer, L. L., Marchant, A., Taton, M., Cools, N., Lion, E., Cassels, F., Higgins, D., Ivinson, K., Locke, E., Mahmood, K., Wright, P. F., Gast, C., White, J. A., Ackerman, M. M., Konopka-Anstadt, J. J., Mainou, B. B., & Van Damme, P. (2023). Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Vaccine, 41(10), 1657-1667. doi:10.1016/j.vaccine.2023.01.048
  12. 24. Kemlin, D., Gemander, N., Depickère, S., Olislagers, V., Georges, D., Waegemans, A., Pannus, P., Lemy, A., Goossens, M. M., Desombere, I., Michiels, J., Vandevenne, M., Heyndrickx, L., Ariën, K. K., Matagne, A., Ackerman, M. M., Le Moine, A., & Marchant, A. (2023). Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients. American Journal of Transplantation. doi:10.1016/j.ajt.2023.02.015
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>